119
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Protective effects of ‘Khamira Abresham Hakim Arshad Wala’, a unani formulation against doxorubicin-induced cardiotoxicity and nephrotoxicity

, , , , &
Pages 41-47 | Received 28 Jul 2010, Accepted 04 Sep 2010, Published online: 10 Nov 2010

References

  • Abdelwahed A, Bouhlel I, Skandrani I, Valenti K, Kadri M, Guiraud P, Steiman R, Mariotte AM, Ghedira K, Laporte F, Dijoux-Franca MG, Chekir-Ghedira L. 2007. Study of antimutagenic and antioxidant activities of gallic acid and 1,2,3,4,6-pentagalloylglucose from Pistacia lentiscus. Confirmation by microarray expression profiling. Chem Biol Interact 165:1–13.
  • Abdel-Wahhab MA, Aly SE. 2005. Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during aflatoxicosis. J Appl Tox 25:218–223.
  • Afanas’ev IB, Dorozhko AI, Brodskii AV, Kostyuk SA, Potapovitch AI. 1989. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 38:1763–1769.
  • Arafa HM, Abd-ellah MF, Hafez HF. 2005. Abatement by naringenin of doxorubicin-induced cardiac toxicity in rats. J Egyptian Nat Cancer Inst 17:291–300.
  • Belur B, Kandaswamy N, Mukherjee KL. 1990. Laboratory technology – A procedure manual for routine diagnostic tests. Delhi: Tata McGraw Hill Co. Ltd. pp 1124–1188.
  • Bernard J. 1967. Acute leukemia treatment. Cancer Res 26:2565–2569.
  • Beutler IR, Duron O, Kelly BM. 1963. Improved method of determination of blood glutathione. J Lab Clin Med 61:882–888.
  • Bones RW, Tausky HH. 1945. The colorimetric determination of creatinine by Jaffe reaction. J Biol Chem 158:581.
  • Carter SK. 1972. Single and combination nonhormonal chemotherapy in breast cancer. Cancer 30:1540–1555.
  • Chularojmontri L, Wattanapitayakul SK., Herunsalee A, Charuchongkolwongse S, Niumsakul S, Srichairat S. 2005. Antioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity. Biol Pharm Bull 28:1165–1171.
  • Cories EP, Ellison RR, Yates JN. 1972. Adriamycin in the treatment of acute myelocytic leukemia. Cancer Chemotherapy Rep 1:237–243.
  • Dash R, Acharya C, Bindu PC, Kundu SC. 2008. Antioxidant potential of silk protein sericin against hydrogen peroxide-induced oxidative stress in skin fibroblasts. BMB Rep 41:236–241.
  • Davidson MH, Maki KC, Dicklin MR, Feinstein SB, Witchger M, Bell M, McGuire DK, Provost JC, Liker H, Aviram M. 2009. Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am J Cardiol 104:936–942.
  • Deepa PR, Varalakshmi P. 2003. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity. Chem Biol Interact 146:201–210.
  • Doroshow JH. 1983. Effect of anthracycline antibiotics on oxygen free radical formation in rat heart. Cancer Res 43:460–472.
  • Dziegiel P, Jethon Z, Suder E, Sopel M, Rabczyński J, Surowiak P, Zabel M. 2002. Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat. Exp. Toxicol Pathol 53:433–439.
  • Elberry AA, Abdel-Naim AB, Abdel-Sattar EA, Nagy AA, Mosli HA, Mohamadin AM, Ashour OM. 2010. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. Food Chem Toxicol 48:1178–1184.
  • El-Shitany NA., El-Haggar S, El-desoky K. 2008. silymarin prevents adriamycin induced cardiotoxicity and nephrotoxicity in rats. Food Chem Toxic 46:2422–2428.
  • Evans CW. 1996. Trease and Evans’ pharmacognosy. London: W.B. Sauders. pp 612.
  • Goyal S, Siddiqui MK, Siddiqui KM, Arora S, Mittal R, Joshi S, Arya DS. 2010. Cardioprotective effect of ‘Khamira Abresham Hakim Arshad Wala’ a Unani formulation in isoproterenol-induced myocardial necrosis in rats. Exp Toxicol Pathol 62:61–74.
  • Hirayama C, Ono H, Tamura Y, Nakamura M. 2006. C-prolinylquercetins from the yellow cocoon shell of the silkworm, Bombyx mori. Phytochemistry 67:579–583.
  • Jiao S, Huang C, Wang H, Yu S. 2007. Effects of citrus aurantium extract on liver antioxidant defense function in experimental diabetic mouse. Wei Sheng Yan Jiu 36:689–692.
  • Khan M, Chandra J, Krishna I, Umamaheshwara M, Naidu R, Kutala V. 2005. Protective effect ofspirulina against doxorubicin induced cardiotoxicity. Phytother Res 19:1031–1035.
  • Khan MB, Hoda MN, Yousuf S, Ishrat T, Ahmad M, Ahmad AS, Alavi SH, Haque N, Islam F. 2006. Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala. J Ethnopharmacol 108:68–73.
  • Kishore RK, Sudhakar D, Parthasarathy PR. 2009. Embryo protective effect of pomegranate (Punica granatum L.) fruit extract in adriamycin-induced oxidative stress. Ind J Biochem Biophys 46:106–11.
  • Kotamraju S, Konorev EA, Joseph J. 2000. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem 275:33585–33592.
  • Kumar D, Kirshenbaum, L.A., Danelisen, I., Singal, P.K. 2001. Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxid Redox Signal 3:135–145.
  • Kurioka A, Yamazaki M. 2002. Purification and identification of flavonoids from the yellow green cocoon shell (Sasamayu) of the silkworm, Bombyx mori. Biosc Biotechnol Biochem 66:1396–1399.
  • Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. 1973. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32:302–314.
  • Leontowicz M, Gorinstein S, Leontowicz H, Krzeminski R, Lojek A, Katrich E, Cíz M, Martin-Belloso O, Soliva-Fortuny R, Haruenkit R, Trakhtenberg S. 2003. Apple and pear peel and pulp and their influence on plasma lipids and antioxidant potentials in rats fed cholesterol-containing diets. J Agr Food Chem 51:5780–5785.
  • Liu L, Shan S, Zhang K, Ning ZQ, Lu XP, Cheng YY. 2008. Naringenin and hesperetin, two flavonoids derived from citrus aurantium up-regulate transcription of adiponectin. Phytother Res 22:1400–1403.
  • Lowry OH, Rosenburg NJ, Farr AL, Randall RJ. 1951. Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275.
  • Luck H. 1971. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: New York Academic Press. pp 885–893.
  • Lum G, Gambino SR. 1974. A comparison of serum versus heparinised plasma for routine chemistry tests. Am J Clin Pathol 61:108–113.
  • Lyle N, Bhattacharyya D, Munshi S, Chatterjee S, Gomes A. 2009. Stress modulating antioxidant effect of Nardostachys jatamansi. Ind J Biochem Biophys 46:93–98.
  • Mishra A, Bhatti R, Singh A, Singh IMP. 2010. Ameliorative effect of the cinnamon oil from cinnamomum zeylanicum upon early stage diabetic nephropathy. Planta Med 76:412–417.
  • Myers CE. 1982. The role of free radical damage in the genesis of doxorubicin cardiac toxicity. In: Muggia FM, Young CW, Carters K, editors. Anthracycline antibiotics in cancer chemotherapy. The Hague: Martinus Nijhoff. pp 297–305.
  • Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. 1977. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197:165–167.
  • Ohkawa H, Oshishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 95:351–358.
  • Pinna A, Agen C, Di Paolo A, Innocenti F, Nardini D, Danesi R, Del Tacca M. 1994. Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3’-deamino-3’-(2-methoxy-4-morpholinyl)doxorubicin and 4’-deoxy-4’-iodo-doxorubicin. J Environ. Pathol Toxicol Oncol 13:25–31.
  • Rajaprabhul D, Rajesh R, Jeyakumar R, Buddhan S, Ganesan B, Anandan R. 2007. Protective effect of Picrorhiza kurroa on antioxidant defense status in adriamycin-induced cardiomyopathy in rats. J Med Plant Res 1:80–85.
  • Reitman S, Frankel AS. 1957. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transminases. Am J Clin Pathol 28:53–56.
  • Saad SY, Najjar TA, Al-Rikabi AC. 2001. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 43:211–218.
  • Scholey JW, Miller PL, Rennke HG, Meyer TW. 1989. Effect of converting enzyme inhibition on the course of adriamycin induced nephropathy. Kidney Int 36:816–822.
  • Sedlack J, Lindsay RH. 1968. Estimation of total, protein bound and non-protein bound sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205.
  • Sengul M, Yildiz H, Gungor N, Cetin B, Ercisli S. 2009. Total phenolic content, antioxidant and antimicrobial activities of some medicinal plants. Pak J Pharm Sci 22:102–106.
  • Singal PK, Deally CM, Weinberg LE. 1987. Subcellular effects of adriamycin in the heart: a concise review. J Mol Cell Cardiol 19:817–828.
  • Singal PK, Iliskovic N. 1998. Doxorubicin-induced cardiomyopathy. N Eng J Med 339:900–905.
  • Siveski-Iliskovic N, Hill M, Chow DA. 1995. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 91:10–15.
  • Straubinger M, Jezussek M, Waibel R, Winterhalter P. 1997. Two kaempferol sophorosides from Crocus sativus. Nat Prod Lett 10:213–216.
  • Subashini R, Yogeeta S, Gnanapragasam A, Devaki T. 2006. Protective effect of Nardostachys jatamansi on oxidative injury and cellular abnormalities during doxorubicin-induced cardiac damage in rats. J Pharm Pharmacol 58:257–262.
  • Teitz NW. 1976. Clinical guide to laboratory test. Philadelphia: WB Saunders Co. pp 238.
  • Wahab MH, El-Mahdy MF, Helal GK, Khalifa F, Hamada FMA. 2003. Influence of p-coumaric acid on doxorubicin induced oxidative stress in rats heart. Pharmac Res 48:461–465.
  • Wattanapitayakul SK, Chularojmontri L, Herunsalee A, Charuchongkolwongse S, Niumsakul S, Bauer JA. 2005. Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity. Basic Clin Pharmacol Toxicol 96:80–87.
  • WHO. 2002. Traditional medicine; Growing needs and potential. WHO policy perspectives on medicines. Geneva: World Health Organization. pp 1–6.
  • Yilmaz S, Atessahin A, Sahna E, Ozers. 2006. Protective effect of lycopen on adriamycin-induced cardiotoxicity nephrotoxicity. Toxicology 218:164–171.
  • Yin X, Wu H, Chen Y, Kang YJ. 1998. Induction of antioxidants by adriamycin in mouse heart. Biochem Pharmacol 56:87–93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.